AgomAb Therapeutics Expands Senior Team with General Counsel and Head of Clinical Operations

AgomAb Therapeutics NV (‘AgomAb’) announced today the appointment of two new members to its senior team to further strengthen the company’s clinical, legal and corporate development capabilities. Ellen Lefever will join AgomAb as General Counsel, bringing extensive legal and transaction experience in the biotech industry.